GoodRx Holdings
GDRX
218 hedge funds and large institutions have $5.73B invested in GoodRx Holdings in 2021 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 45 increasing their positions, 68 reducing their positions, and 38 closing their positions.
53% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 38
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
12% more capital invested
Capital invested by funds: $5.11B → $5.73B (+$618M)
10% more funds holding
Funds holding: 199 → 218 (+19)
17% less call options, than puts
Call options by funds: $138M | Put options by funds: $166M
18.86% less ownership
Funds ownership: 203.91% → 185.06% (-19%)
34% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 68
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$33.1M |
| 2 |
PTC
Petrus Trust Company
Dallas,
Texas
|
+$28.3M |
| 3 |
Morgan Stanley
New York
|
+$23.2M |
| 4 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
+$21.2M |
| 5 |
TCP
ThornTree Capital Partners
Boston,
Massachusetts
|
+$19.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$57.7M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$45.1M |
| 3 |
AM
Atreides Management
Boston,
Massachusetts
|
-$40.6M |
| 4 |
LCG
Luxor Capital Group
New York
|
-$21M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$19.4M |
GDRX Hedge Fund Activity: Q3 2021 in Review
218 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2021, worth a combined $5.73B — up 12% from $5.11B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new GDRX positions and 38 closed out — a net gain of 20 holders — while 45 added to existing stakes and 68 trimmed.
The largest buyer was Marshall Wace, adding an estimated $33.1M. The largest seller was Goldman Sachs, cutting an estimated $57.7M.
- 218 institutional investors held GoodRx Holdings (GDRX) as of Q3 2021, up from 199 in Q2 2021.
- Funds reported $5.73B of GoodRx Holdings stock for Q3 2021, up 12% quarter-over-quarter.
- 58 funds opened new GoodRx Holdings positions in Q3 2021 and 38 closed out, a net change of +20 holders.
- The largest GoodRx Holdings buyer in Q3 2021 was Marshall Wace, an estimated $33.1M added.
- The largest GoodRx Holdings seller in Q3 2021 was Goldman Sachs, an estimated $57.7M sold.
Based on aggregated 13F filings for Q3 2021.